Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Lubiprostone in Slow Transit Constipation
NCT07277907Phase 3Recruiting
- Sponsor
- Army Medical University
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cobiprostone in Slow-transit constipation (STC), sponsored by Army Medical University. Started Nov 2025; status: recruiting.
02
Drugs
cobiprostone
03
Conditions
Slow-transit constipation (STC)
Beyond the preview
Go deeper on NCT07277907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07277907.